20.02.2013 Views

CHUNG, SOONKYU, Ph. D. Mechanisms by Which Conjugated ...

CHUNG, SOONKYU, Ph. D. Mechanisms by Which Conjugated ...

CHUNG, SOONKYU, Ph. D. Mechanisms by Which Conjugated ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CLA is potentially effective in: 1) reducing the growth of tumors <strong>by</strong> inducing apoptosis<br />

(Park et al. 2004) or <strong>by</strong> inhibiting proliferation (Kemp et al. 2003); 2) decreasing the risk<br />

of cardiovascular disease <strong>by</strong> reducing atherosclerotic lesions (Valeille et al. 2004); and 3)<br />

enhancing immune competence <strong>by</strong> modulating inflammatory responses (Yamasaki et al.<br />

2004).<br />

In contrast to the aforementioned physiological benefits exerted <strong>by</strong> CLA isomers, it<br />

has been shown that the trans-10, cis-12 CLA isomer is solely responsible for reducing<br />

adiposity. It was first reported that 20-200 µM of a crude mixture of CLA isomers<br />

decreased triglyceride (TG) content in 3T3-L1 adipocytes (Park et al. 1997).<br />

Subsequently, it was demonstrated that CLA’s ability to reduce body fat was primarily<br />

due to trans-10, cis-12 CLA in vitro and in vivo (Park et al. 1999). Trans-10, cis-12 CLA<br />

decreased adiposity in porcine (Ostrowska et al. 1999) and hamster (Navarro et al. 2003)<br />

models. In support of these in vivo data, our group has demonstrated that human adipose<br />

tissue is a target of trans-10, cis-12 CLA <strong>by</strong> showing that 3-30 µM trans-10, cis-12 CLA<br />

decreased the expression of markers of preadipocyte differentiation (Brown et al. 2003)<br />

and reduced TG content in primary human stomal vascular (SV) cultures containing<br />

newly differentiated adipocytes (Brown et al. 2004).<br />

4

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!